This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Brian Avanzino, Ph.D.
Scientist III, Discovery at TeneoBio


Brian Avanzino is a Scientist III in the Discovery group at Teneobio where he leads a team investigating a novel T-cell redirecting platform for the treatment of both solid and liquid tumors. He received a PhD in Biochemistry and Molecular Biology from UC Davis where he studied regulation of viral translation.

Agenda Sessions

  • Bispecific T cell Engagers

  • Development of a Novel Multivalent T-Cell Redirecting Bispecific Antibody for Selective Killing of Solid Tumor Cells

    On Demand